SNCA and Cognitive impairment: On the other hand, a longitudinal study conducted by Toledo et al. found no significant differences in mean CSF α-synuclein levels at baseline between controls with normal cognitive functions, patients with mild cognitive impairment, and Alzheimer’s disease patients [381].